Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding - PubMed (original) (raw)
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB(1) and CB(2) receptor binding
M M Aung et al. Drug Alcohol Depend. 2000.
Abstract
The N-1 alkyl side chain of the aminoalkylindole analogues (AAI) has been implicated as one of a three-point interaction with the cannabinoid CB(1) receptor. In this study, the morpholinoethyl of WIN 55,212-2 was replaced with carbon chains of varying lengths ranging from a methyl to heptyl group. Additional groups were added to the naphthoyl and the C2 positions of the molecule. These structural changes revealed that high affinity binding to the CB(1) and CB(2) receptors requires an alkyl chain length of at least three carbons with optimum binding to both receptors occurring with a five carbon side chain. An alkyl chain of 3-6 carbons is sufficient for high affinity binding; however, extension of the chain to a heptyl group results in a dramatic decrease in binding at both receptors. The unique structure of the cannabimimetic indoles provides a useful tool to define the ligand-receptor interaction at both cannabinoid receptors and to refine proposed pharmacophore models.
Similar articles
- The bioactive conformation of aminoalkylindoles at the cannabinoid CB1 and CB2 receptors: insights gained from (E)- and (Z)-naphthylidene indenes.
Reggio PH, Basu-Dutt S, Barnett-Norris J, Castro MT, Hurst DP, Seltzman HH, Roche MJ, Gilliam AF, Thomas BF, Stevenson LA, Pertwee RG, Abood ME. Reggio PH, et al. J Med Chem. 1998 Dec 17;41(26):5177-87. doi: 10.1021/jm9801197. J Med Chem. 1998. PMID: 9857088 - 3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptor.
Huffman JW, Mabon R, Wu MJ, Lu J, Hart R, Hurst DP, Reggio PH, Wiley JL, Martin BR. Huffman JW, et al. Bioorg Med Chem. 2003 Feb 20;11(4):539-49. doi: 10.1016/s0968-0896(02)00451-0. Bioorg Med Chem. 2003. PMID: 12538019 - Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.
Shim JY, Collantes ER, Welsh WJ, Subramaniam B, Howlett AC, Eissenstat MA, Ward SJ. Shim JY, et al. J Med Chem. 1998 Nov 5;41(23):4521-32. doi: 10.1021/jm980305c. J Med Chem. 1998. PMID: 9804691 - Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids.
Wiley JL, Marusich JA, Huffman JW. Wiley JL, et al. Life Sci. 2014 Feb 27;97(1):55-63. doi: 10.1016/j.lfs.2013.09.011. Epub 2013 Sep 23. Life Sci. 2014. PMID: 24071522 Free PMC article. Review. - Recent developments in the medicinal chemistry of cannabimimetic indoles, pyrroles and indenes.
Huffman JW, Padgett LW. Huffman JW, et al. Curr Med Chem. 2005;12(12):1395-411. doi: 10.2174/0929867054020864. Curr Med Chem. 2005. PMID: 15974991 Review.
Cited by
- Structure-Activity Relationship and Functional Evaluation of Cannabinoid Type-1 Receptor.
Wang S, Tian X, Paudel S, Ghil S, Jang CG, Kim KM. Wang S, et al. Biomol Ther (Seoul). 2024 Jul 1;32(4):442-450. doi: 10.4062/biomolther.2023.205. Epub 2024 Jun 7. Biomol Ther (Seoul). 2024. PMID: 38844801 Free PMC article. - Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats.
Uttl L, Szczurowska E, Hájková K, Horsley RR, Štefková K, Hložek T, Šíchová K, Balíková M, Kuchař M, Micale V, Páleníček T. Uttl L, et al. Front Neurosci. 2018 Oct 23;12:703. doi: 10.3389/fnins.2018.00703. eCollection 2018. Front Neurosci. 2018. PMID: 30405327 Free PMC article. - Cannabinergic aminoalkylindoles, including AM678=JWH018 found in 'Spice', examined using drug (Δ(9)-tetrahydrocannabinol) discrimination for rats.
Järbe TU, Deng H, Vadivel SK, Makriyannis A. Järbe TU, et al. Behav Pharmacol. 2011 Sep;22(5-6):498-507. doi: 10.1097/FBP.0b013e328349fbd5. Behav Pharmacol. 2011. PMID: 21836461 Free PMC article. - Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists.
Patel M, Zheng X, Akinfiresoye LR, Prioleau C, Walker TD, Glass M, Marusich JA. Patel M, et al. Eur J Pharmacol. 2024 May 15;971:176549. doi: 10.1016/j.ejphar.2024.176549. Epub 2024 Mar 30. Eur J Pharmacol. 2024. PMID: 38561104 Free PMC article. - A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.
Heal DJ, Gosden J, Smith SL. Heal DJ, et al. Front Psychiatry. 2024 Jun 10;15:1322434. doi: 10.3389/fpsyt.2024.1322434. eCollection 2024. Front Psychiatry. 2024. PMID: 38915848 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous